Icon
+91 94997 68112
Login Register

ZARONTIN (nda012380)- (250MG)

ETHOSUXIMIDE PARKE DAVIS
250MG
No No
Expired Expired
None None
None No
Zarontin is indicated for the control of absence (petit mal) epilepsy.
5 0 5
Total Other Developers 5
Drugs with Suitability Yes
250MG ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********** ******* ******** ***. *********** **** ******* **, **** *****, ***** ******** (**) *****, ****** ****** (***) ***
****** **** ****** *** ***** **** ** *********** ************ **, *********, ****, *********** (***) ***
****** ******* ****** ******* ****** ******* ******* *********** ** **/*,******************, ********* *****, ****** *****, *********, ********* ******, ***** (***) ***
****** ******* ***** *** ********* ******* *************** (*****) **., *** *********** **.**, *** ******* ****, **** **** *** ********** *********** ********, *****, ***** ******, ***** (***) ***
****** ******** ****** *** ******** ****** **** ***. */*/* **** *************** **** ***. *********** *** ******* **, **** *********, *** ****** (**) *****, ****** ****** (***) ***

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.